Electrospun Contrast Agent-Loaded Fibers for Colon-Targeted MRI

Article English OPEN
Bligh, S.W.A. ; Jin, M. ; Yu, D.G. ; Wang, X. ; Geraldes, C.F.G.C. ; Williams, G.R. (2016)
  • Publisher: Wiley
  • Related identifiers: doi: 10.1002/adhm.201500872
  • Subject: UOWSAT | Gd(III) complex, coaxial electrospinning, colon-targeted delivery, core-shell fibers, magnetic resonance imaging

Magnetic resonance imaging is a diagnostic tool used for detecting abnormal organs and tissues, often using Gd(III) complexes as contrast-enhancing agents. In this work, core-shell polymer fibers have been prepared using coaxial electrospinning, with the intent of delivering gadolinium (III) diethylenetriaminepentaacetate hydrate (Gd(DTPA)) selectively to the colon. The fibers comprise a poly(ethylene oxide) (PEO) core loaded with Gd(DTPA), and a Eudragit S100 shell. They are homogeneous, with distinct core-shell phases. The components in the fibers are dispersed in an amorphous fashion. The proton relaxivities of Gd(DTPA) are preserved after electrospinning. To permit easy visualization of the release of the active ingredient from the fibers, analogous materials are prepared loaded with the dye rhodamine B. Very little release is seen in a pH 1.0 buffer, while sustained release is seen at pH 7.4. The fibers thus have the potential to selectively deliver Gd(DTPA) to the colon. Mucoadhesion studies reveal there are strong adhesive forces between porcine colon mucosa and PEO from the core, and the dye-loaded fibers can be successfully used to image the porcine colon wall. The electrospun core-shell fibers prepared in this work can thus be developed as advanced functional materials for effective imaging of colonic abnormalities.
  • References (3)

    [1] a) F. Chen, W. Bu, S. Zhang, J. Liu, W. Fan, L. Zhou, W. Peng and J. Shi, Adv. Funct.

    Mater. 2013, 23, 298-307; b) C. F. Geraldes and S. Laurent, Contrast Media Mol. Imaging [32] P. K. Gupta, S.-H. S. Leung and J. R. Robinson, Bioadhesive Drug Delivery Systems [33] J. D. Smart, Adv. Drug Delivery Rev. 2005, 57, 1556-1568. [34] C. Schiller, C. P. FrÖHlich, T. Giessmann, W. Siegmund, H. MÖNnikes, N. Hosten and W. Weitschies, Aliment. Pharmacol. Ther. 2005, 22, 971-979. [35] F. J. O. Varum, F. Veiga, J. S. Sousa and A. W. Basit, Eur. J. Pharm. Sci. 2010, 40, 335- [36] S. A. Mortazavi and J. D. Smart, J.Controlled Release 1993, 25, 197-203. [37] F. J. O. Varum, F. Veiga, J. S. Sousa and A. W. Basit, Int. J. Pharm. 2011, 420, 11-19.

    Table 2. Proton relaxivity values in PBS (20 MHz, 37 ºC). Results are reported as mean ± SD, n = 3.

  • Metrics
    No metrics available
Share - Bookmark